Update: Fatal and Severe Liver Injuries Associated With Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society/ CDC Recommendations—United States, 2001
- 1 October 2001
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 164 (7), 1319-1320
- https://doi.org/10.1164/ajrccm.164.7.16471
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Rifampin and Pyrazinamide vs Isoniazid for Prevention of Tuberculosis in HIV-Infected PersonsAn International Randomized TrialJAMA, 2000
- Twice weekly tuberculosis preventive therapy in HIV infection in ZambiaAIDS, 1998
- Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infectionThe Lancet, 1998